Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for SOX3_SOX2
Z-value: 1.70
Motif logo
Transcription factors associated with SOX3_SOX2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SOX3
|
ENSG00000134595.6 | SRY-box transcription factor 3 |
|
SOX2
|
ENSG00000181449.2 | SRY-box transcription factor 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SOX2 | hg19_v2_chr3_+_181429704_181429722 | -0.61 | 3.2e-04 | Click! |
| SOX3 | hg19_v2_chrX_-_139587225_139587234 | 0.21 | 2.6e-01 | Click! |
Activity profile of SOX3_SOX2 motif
Sorted Z-values of SOX3_SOX2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_-_1748214 | 8.75 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
| chr6_-_30654977 | 7.89 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
| chr1_-_205419053 | 5.99 |
ENST00000367154.1
|
LEMD1
|
LEM domain containing 1 |
| chr19_-_49864746 | 5.60 |
ENST00000598810.1
|
TEAD2
|
TEA domain family member 2 |
| chr1_-_153029980 | 5.35 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
| chr19_-_51472823 | 5.06 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr10_-_105845674 | 4.72 |
ENST00000353479.5
ENST00000369733.3 |
COL17A1
|
collagen, type XVII, alpha 1 |
| chr15_-_74495188 | 4.28 |
ENST00000563965.1
ENST00000395105.4 |
STRA6
|
stimulated by retinoic acid 6 |
| chr4_-_80993717 | 4.16 |
ENST00000307333.7
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr2_-_216257849 | 4.12 |
ENST00000456923.1
|
FN1
|
fibronectin 1 |
| chr6_+_114178512 | 3.93 |
ENST00000368635.4
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate |
| chr2_-_26205340 | 3.72 |
ENST00000264712.3
|
KIF3C
|
kinesin family member 3C |
| chr1_-_205391178 | 3.72 |
ENST00000367153.4
ENST00000367151.2 ENST00000391936.2 ENST00000367149.3 |
LEMD1
|
LEM domain containing 1 |
| chrX_-_38080077 | 3.64 |
ENST00000378533.3
ENST00000544439.1 ENST00000432886.2 ENST00000538295.1 |
SRPX
|
sushi-repeat containing protein, X-linked |
| chr4_-_103266355 | 3.63 |
ENST00000424970.2
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
| chr12_-_95611149 | 3.50 |
ENST00000549499.1
ENST00000343958.4 ENST00000546711.1 |
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
| chr20_-_56284816 | 3.41 |
ENST00000395819.3
ENST00000341744.3 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
| chr8_-_124553437 | 3.28 |
ENST00000517956.1
ENST00000443022.2 |
FBXO32
|
F-box protein 32 |
| chr5_+_137514687 | 3.23 |
ENST00000394894.3
|
KIF20A
|
kinesin family member 20A |
| chr1_-_153066998 | 3.23 |
ENST00000368750.3
|
SPRR2E
|
small proline-rich protein 2E |
| chr5_+_137514834 | 3.11 |
ENST00000508792.1
ENST00000504621.1 |
KIF20A
|
kinesin family member 20A |
| chr12_+_95611516 | 3.07 |
ENST00000436874.1
|
VEZT
|
vezatin, adherens junctions transmembrane protein |
| chr1_-_6479963 | 2.99 |
ENST00000377836.4
ENST00000487437.1 ENST00000489730.1 ENST00000377834.4 |
HES2
|
hes family bHLH transcription factor 2 |
| chr6_+_64282447 | 2.99 |
ENST00000370650.2
ENST00000578299.1 |
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1 |
| chr14_+_85996471 | 2.99 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
| chr4_-_80994210 | 2.95 |
ENST00000403729.2
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr1_-_153013588 | 2.89 |
ENST00000360379.3
|
SPRR2D
|
small proline-rich protein 2D |
| chr12_-_57634475 | 2.87 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr1_-_17307173 | 2.84 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
| chr2_-_208031542 | 2.82 |
ENST00000423015.1
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
| chr8_-_7274385 | 2.82 |
ENST00000318157.2
|
DEFB4B
|
defensin, beta 4B |
| chr7_+_5632436 | 2.77 |
ENST00000340250.6
ENST00000382361.3 |
FSCN1
|
fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) |
| chr15_-_70388943 | 2.76 |
ENST00000559048.1
ENST00000560939.1 ENST00000440567.3 ENST00000557907.1 ENST00000558379.1 ENST00000451782.2 ENST00000559929.1 |
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
| chr2_+_102314161 | 2.62 |
ENST00000425019.1
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
| chr5_-_16936340 | 2.56 |
ENST00000507288.1
ENST00000513610.1 |
MYO10
|
myosin X |
| chr9_+_124461603 | 2.55 |
ENST00000373782.3
|
DAB2IP
|
DAB2 interacting protein |
| chr14_+_23305760 | 2.55 |
ENST00000311852.6
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted) |
| chr2_+_210444142 | 2.54 |
ENST00000360351.4
ENST00000361559.4 |
MAP2
|
microtubule-associated protein 2 |
| chr11_+_125496619 | 2.54 |
ENST00000532669.1
ENST00000278916.3 |
CHEK1
|
checkpoint kinase 1 |
| chr13_-_24007815 | 2.52 |
ENST00000382298.3
|
SACS
|
spastic ataxia of Charlevoix-Saguenay (sacsin) |
| chr1_-_28520384 | 2.48 |
ENST00000305392.3
|
PTAFR
|
platelet-activating factor receptor |
| chr1_-_26232951 | 2.48 |
ENST00000426559.2
ENST00000455785.2 |
STMN1
|
stathmin 1 |
| chr7_+_73703728 | 2.48 |
ENST00000361545.5
ENST00000223398.6 |
CLIP2
|
CAP-GLY domain containing linker protein 2 |
| chr12_+_53491220 | 2.46 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
| chr21_-_16437126 | 2.44 |
ENST00000318948.4
|
NRIP1
|
nuclear receptor interacting protein 1 |
| chr7_+_134464414 | 2.43 |
ENST00000361901.2
|
CALD1
|
caldesmon 1 |
| chr1_+_171154347 | 2.42 |
ENST00000209929.7
ENST00000441535.1 |
FMO2
|
flavin containing monooxygenase 2 (non-functional) |
| chr21_-_16437255 | 2.37 |
ENST00000400199.1
ENST00000400202.1 |
NRIP1
|
nuclear receptor interacting protein 1 |
| chr7_+_134464376 | 2.35 |
ENST00000454108.1
ENST00000361675.2 |
CALD1
|
caldesmon 1 |
| chr22_+_30792846 | 2.35 |
ENST00000312932.9
ENST00000428195.1 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr4_-_103266219 | 2.34 |
ENST00000394833.2
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
| chr2_+_33172221 | 2.33 |
ENST00000354476.3
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr4_-_80994471 | 2.33 |
ENST00000295465.4
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr20_+_6748311 | 2.30 |
ENST00000378827.4
|
BMP2
|
bone morphogenetic protein 2 |
| chr1_+_209602156 | 2.29 |
ENST00000429156.1
ENST00000366437.3 ENST00000603283.1 ENST00000431096.1 |
MIR205HG
|
MIR205 host gene (non-protein coding) |
| chr3_-_139258521 | 2.27 |
ENST00000483943.2
ENST00000232219.2 ENST00000492918.1 |
RBP1
|
retinol binding protein 1, cellular |
| chr10_+_17272608 | 2.26 |
ENST00000421459.2
|
VIM
|
vimentin |
| chr2_-_224903995 | 2.25 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
| chr5_-_146833485 | 2.22 |
ENST00000398514.3
|
DPYSL3
|
dihydropyrimidinase-like 3 |
| chr13_+_110959598 | 2.22 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
| chr7_-_41742697 | 2.19 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
| chr12_-_67072714 | 2.18 |
ENST00000545666.1
ENST00000398016.3 ENST00000359742.4 ENST00000286445.7 ENST00000538211.1 |
GRIP1
|
glutamate receptor interacting protein 1 |
| chr4_-_80993854 | 2.14 |
ENST00000346652.6
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr12_-_122240792 | 2.12 |
ENST00000545885.1
ENST00000542933.1 ENST00000428029.2 ENST00000541694.1 ENST00000536662.1 ENST00000535643.1 ENST00000541657.1 |
AC084018.1
RHOF
|
AC084018.1 ras homolog family member F (in filopodia) |
| chr9_+_103235365 | 2.07 |
ENST00000374879.4
|
TMEFF1
|
transmembrane protein with EGF-like and two follistatin-like domains 1 |
| chr17_-_7297519 | 2.05 |
ENST00000576362.1
ENST00000571078.1 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
| chr4_-_175443788 | 2.05 |
ENST00000541923.1
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| chr3_-_27525865 | 2.04 |
ENST00000445684.1
|
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7 |
| chr4_+_154387480 | 2.03 |
ENST00000409663.3
ENST00000440693.1 ENST00000409959.3 |
KIAA0922
|
KIAA0922 |
| chr18_+_21719018 | 2.00 |
ENST00000585037.1
ENST00000415309.2 ENST00000399481.2 ENST00000577705.1 ENST00000327201.6 |
CABYR
|
calcium binding tyrosine-(Y)-phosphorylation regulated |
| chr4_-_175443484 | 1.97 |
ENST00000514584.1
ENST00000542498.1 ENST00000296521.7 ENST00000422112.2 ENST00000504433.1 |
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| chr8_+_86376081 | 1.93 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
| chr18_-_28682374 | 1.92 |
ENST00000280904.6
|
DSC2
|
desmocollin 2 |
| chr19_-_49865639 | 1.92 |
ENST00000593945.1
ENST00000601519.1 ENST00000539846.1 ENST00000596757.1 ENST00000311227.2 |
TEAD2
|
TEA domain family member 2 |
| chr2_+_30454390 | 1.92 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
| chr12_-_52845910 | 1.90 |
ENST00000252252.3
|
KRT6B
|
keratin 6B |
| chr12_+_95611569 | 1.89 |
ENST00000261219.6
ENST00000551472.1 ENST00000552821.1 |
VEZT
|
vezatin, adherens junctions transmembrane protein |
| chr3_-_141747950 | 1.88 |
ENST00000497579.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
| chr16_+_58497567 | 1.87 |
ENST00000258187.5
|
NDRG4
|
NDRG family member 4 |
| chr7_-_148581251 | 1.87 |
ENST00000478654.1
ENST00000460911.1 ENST00000350995.2 |
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
| chr1_-_26232522 | 1.86 |
ENST00000399728.1
|
STMN1
|
stathmin 1 |
| chr11_+_60691924 | 1.84 |
ENST00000544065.1
ENST00000453848.2 ENST00000005286.4 |
TMEM132A
|
transmembrane protein 132A |
| chr17_+_36584662 | 1.84 |
ENST00000431231.2
ENST00000437668.3 |
ARHGAP23
|
Rho GTPase activating protein 23 |
| chr14_+_100070869 | 1.84 |
ENST00000502101.2
|
RP11-543C4.1
|
RP11-543C4.1 |
| chr13_-_25745857 | 1.83 |
ENST00000381853.3
|
AMER2
|
APC membrane recruitment protein 2 |
| chr12_+_70760056 | 1.83 |
ENST00000258111.4
|
KCNMB4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
| chr4_-_103266626 | 1.83 |
ENST00000356736.4
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
| chr18_+_21718924 | 1.80 |
ENST00000399496.3
|
CABYR
|
calcium binding tyrosine-(Y)-phosphorylation regulated |
| chr17_-_7297833 | 1.79 |
ENST00000571802.1
ENST00000576201.1 ENST00000573213.1 ENST00000324822.11 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
| chr1_+_25071848 | 1.77 |
ENST00000374379.4
|
CLIC4
|
chloride intracellular channel 4 |
| chr16_+_30934376 | 1.71 |
ENST00000562798.1
ENST00000471231.2 |
FBXL19
|
F-box and leucine-rich repeat protein 19 |
| chr5_-_157002775 | 1.71 |
ENST00000257527.4
|
ADAM19
|
ADAM metallopeptidase domain 19 |
| chr3_+_186915274 | 1.69 |
ENST00000312295.4
|
RTP1
|
receptor (chemosensory) transporter protein 1 |
| chr1_-_6545502 | 1.69 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
| chr20_-_13971255 | 1.69 |
ENST00000284951.5
ENST00000378072.5 |
SEL1L2
|
sel-1 suppressor of lin-12-like 2 (C. elegans) |
| chr2_+_65215604 | 1.69 |
ENST00000531327.1
|
SLC1A4
|
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
| chr6_-_27880174 | 1.68 |
ENST00000303324.2
|
OR2B2
|
olfactory receptor, family 2, subfamily B, member 2 |
| chr14_-_57272366 | 1.68 |
ENST00000554788.1
ENST00000554845.1 ENST00000408990.3 |
OTX2
|
orthodenticle homeobox 2 |
| chr15_+_90744533 | 1.67 |
ENST00000411539.2
|
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
| chr1_-_28520447 | 1.67 |
ENST00000539896.1
|
PTAFR
|
platelet-activating factor receptor |
| chr2_-_9771075 | 1.65 |
ENST00000446619.1
ENST00000238081.3 |
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta |
| chr22_+_27053422 | 1.64 |
ENST00000413665.1
ENST00000421151.1 ENST00000456129.1 ENST00000430080.1 |
MIAT
|
myocardial infarction associated transcript (non-protein coding) |
| chr2_-_75796837 | 1.63 |
ENST00000233712.1
|
EVA1A
|
eva-1 homolog A (C. elegans) |
| chrX_+_135251783 | 1.63 |
ENST00000394153.2
|
FHL1
|
four and a half LIM domains 1 |
| chr18_-_31802282 | 1.63 |
ENST00000535475.1
|
NOL4
|
nucleolar protein 4 |
| chr19_-_19051927 | 1.63 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
| chr8_-_105601134 | 1.63 |
ENST00000276654.5
ENST00000424843.2 |
LRP12
|
low density lipoprotein receptor-related protein 12 |
| chr1_+_16085244 | 1.62 |
ENST00000400773.1
|
FBLIM1
|
filamin binding LIM protein 1 |
| chr7_-_148580563 | 1.60 |
ENST00000476773.1
|
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
| chrX_+_135229600 | 1.59 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
| chr18_+_56530794 | 1.58 |
ENST00000590285.1
ENST00000586085.1 ENST00000589288.1 |
ZNF532
|
zinc finger protein 532 |
| chr7_-_107643674 | 1.58 |
ENST00000222399.6
|
LAMB1
|
laminin, beta 1 |
| chr17_+_65374075 | 1.57 |
ENST00000581322.1
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1 |
| chr3_+_141105235 | 1.57 |
ENST00000503809.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
| chrX_+_135252050 | 1.56 |
ENST00000449474.1
ENST00000345434.3 |
FHL1
|
four and a half LIM domains 1 |
| chr22_-_32555275 | 1.55 |
ENST00000382097.3
|
C22orf42
|
chromosome 22 open reading frame 42 |
| chr4_+_54966198 | 1.54 |
ENST00000326902.2
ENST00000503800.1 |
GSX2
|
GS homeobox 2 |
| chr12_-_8815215 | 1.54 |
ENST00000544889.1
ENST00000543369.1 |
MFAP5
|
microfibrillar associated protein 5 |
| chr7_+_107301065 | 1.53 |
ENST00000265715.3
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4 |
| chrX_+_12993336 | 1.53 |
ENST00000380635.1
|
TMSB4X
|
thymosin beta 4, X-linked |
| chr4_-_175443943 | 1.52 |
ENST00000296522.6
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| chr2_+_54683419 | 1.50 |
ENST00000356805.4
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1 |
| chr22_-_36357671 | 1.49 |
ENST00000408983.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
| chr15_+_63335899 | 1.48 |
ENST00000561266.1
|
TPM1
|
tropomyosin 1 (alpha) |
| chr4_+_156680143 | 1.47 |
ENST00000505154.1
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
| chr3_-_48470838 | 1.47 |
ENST00000358459.4
ENST00000358536.4 |
PLXNB1
|
plexin B1 |
| chr9_-_131940526 | 1.47 |
ENST00000372491.2
|
IER5L
|
immediate early response 5-like |
| chrX_+_135229559 | 1.46 |
ENST00000394155.2
|
FHL1
|
four and a half LIM domains 1 |
| chr20_-_5591626 | 1.45 |
ENST00000379019.4
|
GPCPD1
|
glycerophosphocholine phosphodiesterase GDE1 homolog (S. cerevisiae) |
| chr20_-_56285595 | 1.45 |
ENST00000395816.3
ENST00000347215.4 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
| chr12_-_25055177 | 1.45 |
ENST00000538118.1
|
BCAT1
|
branched chain amino-acid transaminase 1, cytosolic |
| chr18_+_3448455 | 1.45 |
ENST00000549780.1
|
TGIF1
|
TGFB-induced factor homeobox 1 |
| chr9_+_124103625 | 1.45 |
ENST00000594963.1
|
AL161784.1
|
Uncharacterized protein |
| chr2_-_235405168 | 1.44 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr1_-_26233423 | 1.43 |
ENST00000357865.2
|
STMN1
|
stathmin 1 |
| chr7_-_148581360 | 1.42 |
ENST00000320356.2
ENST00000541220.1 ENST00000483967.1 ENST00000536783.1 |
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
| chr7_+_23146271 | 1.42 |
ENST00000545771.1
|
KLHL7
|
kelch-like family member 7 |
| chrX_+_135251835 | 1.41 |
ENST00000456445.1
|
FHL1
|
four and a half LIM domains 1 |
| chr1_+_50569575 | 1.41 |
ENST00000371827.1
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4 |
| chr6_-_112115074 | 1.41 |
ENST00000368667.2
|
FYN
|
FYN oncogene related to SRC, FGR, YES |
| chr1_-_201123546 | 1.40 |
ENST00000435310.1
ENST00000485839.2 ENST00000367330.1 |
TMEM9
|
transmembrane protein 9 |
| chr2_+_102953608 | 1.40 |
ENST00000311734.2
ENST00000409584.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
| chr14_+_32798462 | 1.39 |
ENST00000280979.4
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr6_+_41040678 | 1.38 |
ENST00000341376.6
ENST00000353205.5 |
NFYA
|
nuclear transcription factor Y, alpha |
| chr9_+_116638562 | 1.37 |
ENST00000374126.5
ENST00000288466.7 |
ZNF618
|
zinc finger protein 618 |
| chr7_+_77167343 | 1.37 |
ENST00000433369.2
ENST00000415482.2 |
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
| chr14_-_73493784 | 1.37 |
ENST00000553891.1
|
ZFYVE1
|
zinc finger, FYVE domain containing 1 |
| chr14_+_32798547 | 1.37 |
ENST00000557354.1
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr1_-_154155595 | 1.36 |
ENST00000328159.4
ENST00000368531.2 ENST00000323144.7 ENST00000368533.3 ENST00000341372.3 |
TPM3
|
tropomyosin 3 |
| chr8_+_39759794 | 1.35 |
ENST00000518804.1
ENST00000519154.1 ENST00000522495.1 ENST00000522840.1 |
IDO1
|
indoleamine 2,3-dioxygenase 1 |
| chr4_+_144303093 | 1.34 |
ENST00000505913.1
|
GAB1
|
GRB2-associated binding protein 1 |
| chr22_+_30792980 | 1.34 |
ENST00000403484.1
ENST00000405717.3 ENST00000402592.3 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr7_+_18535346 | 1.34 |
ENST00000405010.3
ENST00000406451.4 ENST00000428307.2 |
HDAC9
|
histone deacetylase 9 |
| chr1_-_201123586 | 1.33 |
ENST00000414605.2
ENST00000367334.5 ENST00000367332.1 |
TMEM9
|
transmembrane protein 9 |
| chr2_-_9143786 | 1.32 |
ENST00000462696.1
ENST00000305997.3 |
MBOAT2
|
membrane bound O-acyltransferase domain containing 2 |
| chr12_-_95009837 | 1.31 |
ENST00000551457.1
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
| chr22_-_38713428 | 1.31 |
ENST00000403904.1
ENST00000405675.3 |
CSNK1E
|
casein kinase 1, epsilon |
| chr2_+_17721230 | 1.31 |
ENST00000457525.1
|
VSNL1
|
visinin-like 1 |
| chr14_+_85996507 | 1.31 |
ENST00000554746.1
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
| chrX_+_69509927 | 1.30 |
ENST00000374403.3
|
KIF4A
|
kinesin family member 4A |
| chr5_-_147211226 | 1.30 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr5_-_157002749 | 1.30 |
ENST00000517905.1
ENST00000430702.2 ENST00000394020.1 |
ADAM19
|
ADAM metallopeptidase domain 19 |
| chr21_+_30671690 | 1.29 |
ENST00000399921.1
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
| chr5_-_147211190 | 1.28 |
ENST00000510027.2
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr17_-_18585131 | 1.28 |
ENST00000443457.1
ENST00000583002.1 |
ZNF286B
|
zinc finger protein 286B |
| chr2_+_33172012 | 1.27 |
ENST00000404816.2
|
LTBP1
|
latent transforming growth factor beta binding protein 1 |
| chr17_-_73149921 | 1.27 |
ENST00000481647.1
ENST00000470924.1 |
HN1
|
hematological and neurological expressed 1 |
| chr12_+_22778291 | 1.27 |
ENST00000545979.1
|
ETNK1
|
ethanolamine kinase 1 |
| chr2_+_210444748 | 1.26 |
ENST00000392194.1
|
MAP2
|
microtubule-associated protein 2 |
| chr19_+_45409011 | 1.26 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
| chr6_-_32374900 | 1.25 |
ENST00000374995.3
ENST00000374993.1 ENST00000414363.1 ENST00000540315.1 ENST00000544175.1 ENST00000429232.2 ENST00000454136.3 ENST00000446536.2 |
BTNL2
|
butyrophilin-like 2 (MHC class II associated) |
| chr10_-_33247124 | 1.25 |
ENST00000414670.1
ENST00000302278.3 ENST00000374956.4 ENST00000488494.1 ENST00000417122.2 ENST00000474568.1 |
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
| chr4_+_118955500 | 1.25 |
ENST00000296499.5
|
NDST3
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 |
| chr10_+_102759045 | 1.25 |
ENST00000370220.1
|
LZTS2
|
leucine zipper, putative tumor suppressor 2 |
| chr6_+_130339710 | 1.25 |
ENST00000526087.1
ENST00000533560.1 ENST00000361794.2 |
L3MBTL3
|
l(3)mbt-like 3 (Drosophila) |
| chr14_+_76776957 | 1.25 |
ENST00000512784.1
|
ESRRB
|
estrogen-related receptor beta |
| chr17_+_9728828 | 1.24 |
ENST00000262441.5
|
GLP2R
|
glucagon-like peptide 2 receptor |
| chr21_-_40685536 | 1.24 |
ENST00000341322.4
|
BRWD1
|
bromodomain and WD repeat domain containing 1 |
| chr12_+_69979210 | 1.24 |
ENST00000544368.2
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
| chr3_+_39509070 | 1.23 |
ENST00000354668.4
ENST00000428261.1 ENST00000420739.1 ENST00000415443.1 ENST00000447324.1 ENST00000383754.3 |
MOBP
|
myelin-associated oligodendrocyte basic protein |
| chr4_+_156680153 | 1.23 |
ENST00000502959.1
ENST00000505764.1 ENST00000507146.1 ENST00000264424.8 ENST00000503520.1 |
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
| chr10_-_25241499 | 1.23 |
ENST00000376378.1
ENST00000376376.3 ENST00000320152.6 |
PRTFDC1
|
phosphoribosyl transferase domain containing 1 |
| chr22_-_28197486 | 1.22 |
ENST00000302326.4
|
MN1
|
meningioma (disrupted in balanced translocation) 1 |
| chr8_+_124194875 | 1.22 |
ENST00000522648.1
ENST00000276699.6 |
FAM83A
|
family with sequence similarity 83, member A |
| chr11_+_65408273 | 1.21 |
ENST00000394227.3
|
SIPA1
|
signal-induced proliferation-associated 1 |
| chr4_-_40859132 | 1.21 |
ENST00000543538.1
ENST00000502841.1 ENST00000504305.1 ENST00000513516.1 ENST00000510670.1 |
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2 |
| chr12_-_8815299 | 1.20 |
ENST00000535336.1
|
MFAP5
|
microfibrillar associated protein 5 |
| chr2_-_165424973 | 1.20 |
ENST00000543549.1
|
GRB14
|
growth factor receptor-bound protein 14 |
| chr8_+_124194752 | 1.19 |
ENST00000318462.6
|
FAM83A
|
family with sequence similarity 83, member A |
| chr8_-_95449155 | 1.18 |
ENST00000481490.2
|
FSBP
|
fibrinogen silencer binding protein |
| chr12_+_69979446 | 1.18 |
ENST00000543146.2
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
| chr3_+_39509163 | 1.18 |
ENST00000436143.2
ENST00000441980.2 ENST00000311042.6 |
MOBP
|
myelin-associated oligodendrocyte basic protein |
| chr3_+_149689066 | 1.17 |
ENST00000593416.1
|
AC117395.1
|
LOC646903 protein; Uncharacterized protein |
| chr14_+_75746781 | 1.17 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr16_-_46864955 | 1.17 |
ENST00000565112.1
|
C16orf87
|
chromosome 16 open reading frame 87 |
| chr11_+_57365150 | 1.16 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
| chrX_-_132095419 | 1.16 |
ENST00000370836.2
ENST00000521489.1 |
HS6ST2
|
heparan sulfate 6-O-sulfotransferase 2 |
| chr14_-_73493825 | 1.15 |
ENST00000318876.5
ENST00000556143.1 |
ZFYVE1
|
zinc finger, FYVE domain containing 1 |
| chr13_-_30881134 | 1.15 |
ENST00000380617.3
ENST00000441394.1 |
KATNAL1
|
katanin p60 subunit A-like 1 |
| chr18_+_29027696 | 1.15 |
ENST00000257189.4
|
DSG3
|
desmoglein 3 |
Network of associatons between targets according to the STRING database.
First level regulatory network of SOX3_SOX2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 4.9 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 1.4 | 4.1 | GO:1904303 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 1.4 | 4.1 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 1.2 | 3.5 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 1.1 | 5.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.9 | 9.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.8 | 2.5 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.8 | 2.3 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.8 | 2.3 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.8 | 3.0 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.7 | 2.2 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.7 | 3.6 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.7 | 4.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.7 | 7.8 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.7 | 4.2 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.7 | 3.9 | GO:0030421 | defecation(GO:0030421) |
| 0.6 | 1.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.6 | 1.9 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.6 | 1.9 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.5 | 2.6 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.5 | 2.6 | GO:1990834 | response to odorant(GO:1990834) |
| 0.5 | 1.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.5 | 3.0 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.5 | 1.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.5 | 2.8 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.5 | 3.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.5 | 2.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.4 | 2.6 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.4 | 1.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.4 | 2.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.4 | 2.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.4 | 0.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.4 | 1.6 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.4 | 1.1 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.4 | 1.5 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.4 | 4.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 | 1.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.4 | 0.4 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.4 | 1.8 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.4 | 3.6 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.3 | 1.0 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.3 | 1.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.3 | 1.4 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.3 | 2.7 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.3 | 1.0 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.3 | 7.6 | GO:0030903 | notochord development(GO:0030903) |
| 0.3 | 1.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.3 | 1.6 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.3 | 1.3 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.3 | 7.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.3 | 2.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.3 | 1.8 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.3 | 0.9 | GO:1901166 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.3 | 3.3 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 | 1.8 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 | 0.9 | GO:0035570 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.3 | 1.7 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.3 | 1.7 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.3 | 0.8 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.3 | 4.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.3 | 0.8 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.3 | 6.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.3 | 1.9 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.3 | 1.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.3 | 3.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.3 | 0.8 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.3 | 0.8 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.3 | 5.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.3 | 3.9 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.3 | 0.8 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.3 | 9.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 | 1.5 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
| 0.2 | 1.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.2 | 1.0 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 | 1.2 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.2 | 1.4 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.2 | 1.9 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.2 | 1.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 | 1.4 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.2 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 | 0.5 | GO:0051962 | positive regulation of nervous system development(GO:0051962) |
| 0.2 | 5.3 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.2 | 1.3 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.2 | 0.6 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.2 | 1.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.2 | 0.4 | GO:0040013 | negative regulation of locomotion(GO:0040013) |
| 0.2 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 | 1.2 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.2 | 5.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 1.0 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 | 2.4 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.2 | 1.2 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.2 | 0.8 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.2 | 0.4 | GO:0070988 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) demethylation(GO:0070988) |
| 0.2 | 10.6 | GO:1901998 | toxin transport(GO:1901998) |
| 0.2 | 1.5 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.2 | 1.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 | 2.0 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.2 | 1.4 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 2.9 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.2 | 1.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.2 | 1.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.2 | 1.1 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 | 0.5 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.2 | 12.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.2 | 1.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 | 0.9 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 | 0.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 | 0.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.2 | 2.0 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.2 | 0.5 | GO:0006059 | hexitol metabolic process(GO:0006059) inner medullary collecting duct development(GO:0072061) |
| 0.2 | 0.8 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.2 | 0.8 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.2 | 1.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 | 0.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.2 | 0.5 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.2 | 0.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.2 | 0.8 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.2 | 1.5 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 | 1.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 | 1.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.2 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
| 0.2 | 0.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.2 | 0.9 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 4.0 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.2 | 4.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.2 | 0.5 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.2 | 0.3 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.2 | 0.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 | 0.6 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.1 | 1.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 1.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 0.7 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.1 | 0.6 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.1 | 0.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 0.7 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 | 0.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 | 0.4 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.1 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.1 | 1.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 0.8 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 | 0.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.1 | 0.7 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 0.1 | GO:0003249 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 0.1 | 6.6 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 2.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 4.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 0.8 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 1.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.1 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.1 | 0.5 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.1 | 0.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 0.6 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.1 | 2.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 1.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 | 1.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.1 | 1.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.1 | 2.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.5 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.1 | 0.6 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
| 0.1 | 0.3 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.1 | 0.3 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.1 | 0.3 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.1 | 0.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.1 | 1.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 0.3 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 | 0.3 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 | 0.6 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.1 | 3.8 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.1 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.1 | 1.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.1 | 0.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.1 | 1.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 0.7 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 | 1.2 | GO:0009629 | response to gravity(GO:0009629) |
| 0.1 | 0.4 | GO:0021650 | vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
| 0.1 | 1.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 0.6 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.1 | 0.4 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.1 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.1 | 0.3 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.1 | 0.7 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.1 | 1.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 0.2 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
| 0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.1 | 0.3 | GO:0048627 | myoblast development(GO:0048627) |
| 0.1 | 0.8 | GO:0060346 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
| 0.1 | 0.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.1 | 0.7 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.1 | 0.3 | GO:0014045 | chronological cell aging(GO:0001300) establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
| 0.1 | 0.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 | 0.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
| 0.1 | 0.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 | 0.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 | 4.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 | 0.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.1 | 0.9 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.1 | 1.3 | GO:0099515 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
| 0.1 | 0.9 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.1 | 0.4 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.1 | 0.3 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
| 0.1 | 1.7 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.1 | 1.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 | 2.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 0.8 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.1 | 0.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.1 | 0.7 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.1 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.1 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.1 | 0.7 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.1 | 4.1 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 | 1.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 0.2 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.1 | 0.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.1 | 0.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 | 0.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.1 | 0.4 | GO:0060613 | fat pad development(GO:0060613) |
| 0.1 | 0.3 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 | 0.4 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.1 | 0.3 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.1 | 0.7 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
| 0.1 | 2.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.1 | 2.7 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 0.2 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.1 | 0.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 | 0.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 0.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 | 0.2 | GO:1904530 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.1 | 0.4 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 | 0.5 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 0.9 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
| 0.1 | 0.4 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 | 1.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 0.4 | GO:0030805 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 | 0.7 | GO:1903416 | regulation of resting membrane potential(GO:0060075) response to glycoside(GO:1903416) |
| 0.1 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.1 | 1.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 0.2 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.1 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 0.5 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.1 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 0.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.1 | 1.0 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 1.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.1 | 0.1 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.3 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.1 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.2 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.1 | 0.5 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.1 | 0.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.1 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.1 | 1.1 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 2.7 | GO:0016337 | single organismal cell-cell adhesion(GO:0016337) |
| 0.1 | 0.9 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.1 | 0.7 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
| 0.1 | 0.2 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 | 0.2 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 | 0.4 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.1 | 0.8 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.1 | 0.2 | GO:2000523 | defense response to nematode(GO:0002215) regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.1 | 1.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.1 | 0.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.1 | 0.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.1 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 2.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 | 0.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.1 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 0.2 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.1 | 1.3 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.1 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 | 0.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 0.2 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 | 0.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.1 | 0.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.1 | 0.3 | GO:0048263 | determination of dorsal identity(GO:0048263) |
| 0.1 | 0.3 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.1 | 0.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 | 1.6 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 | 1.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 0.5 | GO:0042148 | meiotic DNA recombinase assembly(GO:0000707) strand invasion(GO:0042148) |
| 0.1 | 0.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 | 0.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 | 0.3 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
| 0.1 | 0.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.1 | 0.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.1 | 0.1 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.1 | 1.6 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.1 | 2.1 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 | 0.3 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 | 0.3 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.1 | 0.2 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
| 0.1 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.1 | 1.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 | 0.3 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 | 0.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.0 | 0.5 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.0 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 0.0 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.0 | 0.5 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 0.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 | 0.2 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.0 | 0.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.0 | 0.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.0 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.0 | 0.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.0 | 0.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.0 | 0.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.0 | 0.5 | GO:0070863 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 | 0.7 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 | 0.6 | GO:0031960 | response to corticosteroid(GO:0031960) |
| 0.0 | 1.5 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.0 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.0 | 0.2 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.0 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.0 | 1.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 0.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.0 | 2.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.0 | 0.3 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 | 0.1 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
| 0.0 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.0 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 | 0.0 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 | 1.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.4 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 | 0.2 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.0 | 0.3 | GO:0042262 | DNA protection(GO:0042262) |
| 0.0 | 1.1 | GO:0006312 | mitotic recombination(GO:0006312) |
| 0.0 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
| 0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.0 | 3.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.4 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
| 0.0 | 0.7 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.0 | 3.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
| 0.0 | 0.1 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.0 | 1.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 | 0.6 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.0 | 0.2 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.0 | 3.0 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.0 | 0.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 | 0.5 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.0 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
| 0.0 | 0.3 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
| 0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.0 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 | 0.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.0 | 0.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 0.1 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.0 | 0.6 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.0 | 0.4 | GO:0031034 | myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.0 | 0.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.0 | 0.1 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.0 | 0.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 | 0.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.0 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.0 | 0.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
| 0.0 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.0 | 0.9 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.0 | 0.2 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
| 0.0 | 0.3 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
| 0.0 | 2.2 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 | 0.3 | GO:0099639 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.0 | 0.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 | 0.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.0 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.0 | 0.3 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.1 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.0 | 0.1 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.0 | 0.3 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.0 | 0.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.0 | 0.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.0 | 0.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.0 | 0.5 | GO:0030336 | negative regulation of cell migration(GO:0030336) |
| 0.0 | 0.3 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.0 | 0.2 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.0 | 0.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.0 | 0.4 | GO:0021554 | optic nerve development(GO:0021554) |
| 0.0 | 0.3 |